| Mr Sunket Ahkee, MD | |
|
2300 South Congress Ave Ste 100, Boynton Beach, FL 33426 | |
| (561) 735-7531 | |
| (561) 742-8250 |
| Full Name | Mr Sunket Ahkee |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 41 Years |
| Location | 2300 South Congress Ave Ste 100, Boynton Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023111580 | NPI | - | NPPES |
| 5093002 | Other | FL | AETNA |
| 252633600 | Medicaid | FL | |
| 43662 | Other | FL | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME007261 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bethesda Hospital Inc | Boynton beach, FL | Hospital |
| Jfk Medical Center | Atlantis, FL | Hospital |
| Wellington Regional Medical Center Llc | Wellington, FL | Hospital |
| Lakeside Medical Center | Belle glade, FL | Hospital |
| Palms West Hospital | Loxahatchee, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Id Consultants Inc | 5991602963 | 7 |
News Archive
The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
Substantial improvements in the care and survival of older people with hip fracture in England have followed the introduction of a collaborative national initiative to tackle the issue, according to a new study published in the Medical Care journal.
St. Jude Medical, Inc., a global medical device company, today announced two-year results in a post-market clinical study evaluating neurostimulation (spinal cord stimulation) for the management of chronic low back pain. Presented at the 14th annual North American Neuromodulation Society (NANS) meeting in Las Vegas, the study found that 70 percent of neurostimulation patients reported overall pain relief of 50 percent or better at their final two-year visit.
› Verified 3 days ago
| Entity Name | Id Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134217987 PECOS PAC ID: 5991602963 Enrollment ID: O20040129000161 |
News Archive
The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
Substantial improvements in the care and survival of older people with hip fracture in England have followed the introduction of a collaborative national initiative to tackle the issue, according to a new study published in the Medical Care journal.
St. Jude Medical, Inc., a global medical device company, today announced two-year results in a post-market clinical study evaluating neurostimulation (spinal cord stimulation) for the management of chronic low back pain. Presented at the 14th annual North American Neuromodulation Society (NANS) meeting in Las Vegas, the study found that 70 percent of neurostimulation patients reported overall pain relief of 50 percent or better at their final two-year visit.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Sunket Ahkee, MD 2300 South Congress Ave Ste 100, Boynton Beach, FL 33426 Ph: (561) 735-7531 | Mr Sunket Ahkee, MD 2300 South Congress Ave Ste 100, Boynton Beach, FL 33426 Ph: (561) 735-7531 |
News Archive
The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
Substantial improvements in the care and survival of older people with hip fracture in England have followed the introduction of a collaborative national initiative to tackle the issue, according to a new study published in the Medical Care journal.
St. Jude Medical, Inc., a global medical device company, today announced two-year results in a post-market clinical study evaluating neurostimulation (spinal cord stimulation) for the management of chronic low back pain. Presented at the 14th annual North American Neuromodulation Society (NANS) meeting in Las Vegas, the study found that 70 percent of neurostimulation patients reported overall pain relief of 50 percent or better at their final two-year visit.
› Verified 3 days ago
Dr. Jonathan Michael Greer, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6056 Boynton Beach Blvd Ste 145, Boynton Beach, FL 33437 Phone: 561-439-1800 Fax: 561-439-4874 | |
Sheeba Jacob, ARNP Infectious Disease Medicare: Medicare Enrolled Practice Location: 2300 S Congress Ave Ste 100, Boynton Beach, FL 33426 Phone: 561-735-7531 Fax: 561-572-0384 | |
Rogelio A Brito, D.O. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2623 S Seacrest Blvd, Suite 216, Boynton Beach, FL 33435 Phone: 561-742-0065 Fax: 561-742-0105 | |
Dr. Kenneth Lee, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1501 Corporate Dr # Way-240, Boynton Beach, FL 33426 Phone: 561-736-8806 Fax: 561-736-3384 | |
Om Prakash Singh, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2828 S Seacrest Blvd Ste 101, Boynton Beach, FL 33435 Phone: 561-736-1070 Fax: 561-738-5721 | |
Mr. Lawrence H Port, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 8645 W Boynton Beach Blvd, Boynton Beach, FL 33472 Phone: 561-853-1621 |